Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for Anaplastic Large Cell Lymphoma, ALK-Negative
158 locations incl. Birmingham
Sponsor: Eastern Cooperative Oncology Group
Sex: All·Age: 18 - 75
Code: NCT06724237·Phase 3·Recruiting